Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Department of Medicine (Division of Endocrinology and Metabolism, and Division of General Internal Medicine), Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
Am J Hypertens. 2022 Jun 16;35(6):561-571. doi: 10.1093/ajh/hpab189.
Normal-appearing adrenal glands on cross-sectional imaging may still be the source of aldosterone production in primary aldosteronism (PA).
We evaluated the prevalence of aldosterone production among morphologically normal-appearing adrenal glands and the impact of this phenomenon on interpretations of localization studies and treatment decisions. We performed a retrospective cohort study of PA patients with at least 1 normal adrenal gland and reanalyzed contemporary studies to assess interpretations of imaging and adrenal venous sampling (AVS) at the individual patient and adrenal levels.
Among 243 patients, 43 (18%) had bilateral normal-appearing adrenals and 200 (82%) had a unilateral normal-appearing adrenal, for a total of 286 normal-appearing adrenal glands. 38% of these normal-appearing adrenal glands were a source of aldosteronism on AVS, resulting in discordance between imaging and AVS findings in 31% of patients. Most patients with lateralizing PA underwent curative unilateral treatment (80%); however, curative treatment was pursued in 92% of patients who had concordant imaging-AVS results but in only 38% who had discordant results (P < 0.05). In young patients, imaging-AVS discordance was detected in 32% of those under 45 years and 21% of those under 35 years. Among 20 contemporary studies (including 4,904 patients and 6,934 normal-appearing adrenal glands), up to 64% of normal-appearing adrenals were a source of aldosteronism resulting in 31% of patients having discordant results.
Morphologically normal-appearing adrenal glands are commonly the source of aldosterone production in PA, even among young patients. The lack of awareness of this issue may result in inappropriate treatment recommendations.
在原发性醛固酮增多症(PA)中,即使在影像学上表现正常的肾上腺也可能是醛固酮产生的来源。
我们评估了形态学上正常的肾上腺中醛固酮产生的发生率,以及这种现象对定位研究和治疗决策的影响。我们对至少有 1 个正常肾上腺的 PA 患者进行了回顾性队列研究,并重新分析了当代研究,以评估个体患者和肾上腺水平的影像学和肾上腺静脉采样(AVS)的解释。
在 243 例患者中,43 例(18%)双侧肾上腺外观正常,200 例(82%)单侧肾上腺外观正常,共有 286 个外观正常的肾上腺。这些外观正常的肾上腺中有 38%是醛固酮的来源,导致影像学和 AVS 结果在 31%的患者中存在差异。大多数具有侧化 PA 的患者接受了治愈性单侧治疗(80%);然而,在影像学-AVS 结果一致的患者中有 92%接受了治愈性治疗,但在影像学-AVS 结果不一致的患者中只有 38%接受了治疗(P < 0.05)。在年轻患者中,32%的<45 岁患者和 21%的<35 岁患者出现影像学-AVS 差异。在 20 项当代研究(包括 4904 例患者和 6934 个外观正常的肾上腺)中,多达 64%的外观正常的肾上腺是醛固酮的来源,导致 31%的患者结果不一致。
即使在年轻患者中,形态学上正常的肾上腺也常常是 PA 中醛固酮产生的来源。对这一问题认识不足可能导致治疗建议不当。